Watchdog Calls for Tighter Scrutiny of Medicare Advantage Home Visits
Medicare officials defend the use of home visits that often spot medical conditions that are never treated.
Medicare
121 - 140 of 1,576 Results
-
-
Trump’s White House Return Poised To Tangle Health Care Safety Net
The new Trump administration is likely to reduce subsidies for Affordable Care Act insurance plans and roll back Medicaid coverage. Public health authorities worry that anti-vaccine activist Robert F. Kennedy Jr. will be empowered.
-
In Vermont, Where Almost Everyone Has Insurance, Many Can’t Find or Afford Care
Vermont has one of the lowest uninsured rates in the U.S., even though its residents pay some of the highest health insurance costs. Still, most of its hospitals are losing money and patients often face long waits for care.
-
Election Outcome Could Bring Big Changes to Medicare
Democrats and conservatives are divided over whether the federal health program for people over 65 should be run almost entirely by the private sector. If Trump retakes the White House, the shift to Medicare Advantage may accelerate.
-
Trump Wants Harris To Pay a Political Price for Generous Immigrant Health Policies
Several Democratic-led states have expanded public insurance programs to cover immigrants in the U.S. regardless of legal status. Donald Trump is trying to blame Kamala Harris for the policies.
By Joanne Kenen The Campaign’s Final Days
Episode 370It’s the final days of the 2024 campaign, and Republicans are suddenly talking again about making changes to the Affordable Care Act if former President Donald Trump wins. Meanwhile, new reporting uncovers more maternal deaths under state abortion bans — and a case in which a Nevada woman was jailed after a miscarriage. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join ýҕl Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, ýҕl Health News’ Julie Rovner interviews Irving Washington, a senior vice president at KFF and the executive director of its Health Misinformation and Trust Initiative.
-
Vance Wrongly Blames Rural Hospital Closures on Immigrants in the Country Illegally
Experts disputed the claim by Republican vice presidential candidate JD Vance, noting that a range of other issues — from low reimbursement rates to declining patient use — combine to cause these facilities to shutter.
Less Than Two Weeks To Go
Episode 369With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join ýҕl Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.
-
Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.
Every year, Medicare officials encourage beneficiaries to shop around for their drug coverage. Few take the time. This year, it might be more important than ever.
By Susan Jaffe -
Patients Are Relying on Lyft, Uber To Travel Far Distances to Medical Care
Uber and Lyft have become a critical part of the nation’s infrastructure for transporting ailing people from their homes — even in rural areas — to medical care sites in major cities such as Atlanta.
Yet Another Promise for Long-Term Care Coverage
Episode 367As part of her presidential campaign, Vice President Kamala Harris has rolled out a plan for Medicare to provide in-home long-term care services. The proposal would fill a longtime need for families trying to simultaneously care for young children and older parents, but its enormous price tag makes it a promise unlikely to be fulfilled. Meanwhile, a growing number of Republican candidates up and down the ballot facing voter backlash over their support for abortion restrictions are trying to reinvent their positions. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico join ýҕl Health News’ Julie Rovner to discuss these stories and more. Also this week, excerpts from a KFF lunch with “Shark Tank” panelist and generic drug discounter Mark Cuban, who has been consulting with the Harris campaign about health care issues.
The Health of the Campaign
Episode 366The 2024 presidential race is taking on a familiar tone — with Democrats accusing Republicans of wanting to ban abortion and repeal the Affordable Care Act and Republicans insisting they have no such plans. Voters will determine whom they believe. Meanwhile, for the second time in a month, a state judge overturned an abortion ban, but few expect the decision to settle the matter. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Anna Edney of Bloomberg News join ýҕl Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews ýҕl Health News’ Lauren Sausser, who reported and wrote the latest ýҕl Health News-Washington Post “Bill of the Month,” about a teenage athlete whose needed surgery lacked a billing code.
-
Harris Correct That Trump Fell Short on Promise To Negotiate Medicare Drug Prices
The former president instead favored a temporary model that could’ve brought down prices of some prescription drugs, but it was blocked by the courts.
-
The Medicare Advantage Influence Machine
New court filings and lobbying reports reveal an industry drive to tamp down critics — and retain billions of dollars in overcharges.
By Fred Schulte and Holly K. Hacker American Health Under Trump — Past, Present, and Future
Episode 364Dreaming of a Trump victory, Republicans have a wish list of health policy changes — including loosening Affordable Care Act regulations to make cheaper coverage available and ending Medicare drug price negotiations. Meanwhile, after a publicly reported death stemming from a state abortion ban, Vice President Kamala Harris is emphasizing the consequences of Trump’s work to overturn Roe v. Wade. Tami Luhby of CNN, Shefali Luthra of The 19th, and Joanne Kenen of Politico and Johns Hopkins University join ýҕl Health News senior editor Emmarie Huetteman to discuss these stories and more.
Trump-Harris Debate Showcases Health Policy Differences
Episode 363-
Longtime Head of L.A. Care To Retire After Navigating Major Medi-Cal Changes
John Baackes, who steered Medi-Cal’s largest health plan following the Affordable Care Act expansion, and later prepared it for a state overhaul of Medi-Cal, will retire after this year. Baackes believes low payments to doctors and other providers, along with an acute labor shortage, hamper Medi-Cal’s success.
-
Perspective
With TV Drug Ads, What You See Is Not Necessarily What You Get
The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.
-
Feds Killed Plan To Curb Medicare Advantage Overbilling After Industry Opposition
A private 2014 decision by the Centers for Medicare & Medicaid Services faces new scrutiny in a multibillion-dollar Justice Department fraud case against UnitedHealth Group.
By Fred Schulte -
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.